Biobanks Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Biobanks Market is segmented by Equipment, Media, Service (Human Tissue Biobanking, Stem Cell Biobanking, Cord Banking, DNA/RNA Biobanking, and Other Services), Application, and Geography

Market Snapshot

biobank market
Study Period:

2018 - 2026

Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America


9.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors for the growth of the global biobanks market include the innovations in regenerative medicine, the growing incidence of chronic diseases, advances in drug discovery and development, and R&D funding and investments by government and non-governmental organizations. These factors are expected to a boost the growth of the market over the forecast period.

Regenerative medicine through stem cell technology is one of the important treatments for diseases, such as Alzheimer's, diabetes, cancers, and rare genetic diseases. In order to benefit from the existing therapies, umbilical cord cells and other stem cells are preserved.

Stem cell practices are on the rise, globally, and are contributing to the development of new solutions for various diseases. Boston-based biotech start-up, Orig3n, is looking to build the largest and most diverse biobank, harnessing the power of induced pluripotent stem cell technology to accelerate regenerative medicine. Treatments for diseases, like muscular degeneration, using adult stem cells are now going into Phase 3 clinical trials in Japan. These successes are driving both the government and the private sector organizations into investing in more stem cell banks.

With the increase in awareness about stem cell therapies, there have been larger number of parents who are choosing umbilical cord banks for their children. There are a number of donor banks that are coming up as well. Biobanks not only aid in the therapies for genetic diseases, but also in medical research on rare genetic disorders. Increasing awareness about stem cell therapies and innovation in the field of regenerative medicine are driving the growth of the global biobank market.

Scope of the Report

As per the scope of the report, biobank is a biorepository, where various biomaterials (usually human specimens) are stored for research purpose. This study targets gaining a detailed overview of the market dynamics of the contemporary biobank market during the forecast period. It focuses on the need to develop strategic insights into the global and country-level markets, taking into consideration the demand for services and equipment in biobanks.

By Equipment
Cryogenic Storage Systems
Ice Machines
Alarm Monitoring Systems
Other Equipment
By Media
Optimized Media
Non-optimized Media
By Services
Human Tissue Biobanking
Stem Cell Biobanking
Cord Banking
DNA/RNA Biobanking
Other Services
By Application
Regenerative Medicine
Drug Discovery
Disease Research
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cryogenic Storage Segment by Equipment is Expected to Account for the Largest Market Share During the Forecast Period

  • In biobanks, the cryogenic storage systems are basically used to store different life sciences materials at a very low temperature. The low temperature storage increases the longevity of the cells, while at the same time reducing the intensity of freezing damage.
  • Various cryogenic storage devices are available that have been designed to allow storage of both liquid and vapor phase materials. The temperature in the cryogenic storage system is required to be maintained continuously.
  • Currently, all demand is for automated cryogenic storage devices. This segment is further divided into refrigerators, ice machines, and freezers.
  • The advanced storage and automated devices are propelling the growth of the market, steady growth in the North American and European markets is expected.
  • The increasing R&D spending is propelling the demand for biobanks which is in turn helping in the growth of the segment.
Top 10 Cancer Cases in 2018 Worldwide.png

To understand key trends, Download Sample Report

North America Accounted for the Largest Share in the Global Market

  • North America holds a major share in the global biobanks market, and it is expected to show a similar trend over the forecast period, without significant fluctuations.
  • The United States has the largest expenditure for R&D and better healthcare infrastructure in the world. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing biobanks for the storage of DNA, RNA, tissue, serum, blood, plasma, cells, etc.
  • Hence, with the growing R%D expenditure and developed healthcare infrastructure, the region is expected to witness strong market share in the future.
biobank 3.png

To understand geography trends, Download Sample Report

Competitive Landscape

The global biobanks market is moderately consolidated. Some of the segments are dominated by a few major players, while the other segments are distributed among multiple players. The market players are moreover, focusing on collaboration and partnership activities. For instance, BioLife Solutions and SAVSU collaborated to provide enhanced, cold-chain technologies for diabetes, lupus, pemphigus, and organ transplantation in October 2017.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Innovations in Regenerative Medicine

      2. 4.2.2 Growing Incidences of Chronic Diseases

      3. 4.2.3 Advances in Drug Discovery and Development

      4. 4.2.4 Increasing Focus on Personalized Medicine

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Issues

      2. 4.3.2 Cost Constraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Equipment

      1. 5.1.1 Cryogenic Storage Systems

        1. Refrigerators

        2. Ice Machines

        3. Freezers

      2. 5.1.2 Alarm Monitoring Systems

      3. 5.1.3 Other Equipment

    2. 5.2 By Media

      1. 5.2.1 Optimized Media

      2. 5.2.2 Non-optimized Media

    3. 5.3 By Services

      1. 5.3.1 Human Tissue Biobanking

      2. 5.3.2 Stem Cell Biobanking

      3. 5.3.3 Cord Banking

      4. 5.3.4 DNA/RNA Biobanking

      5. 5.3.5 Other Services

    4. 5.4 By Application

      1. 5.4.1 Regenerative Medicine

      2. 5.4.2 Drug Discovery

      3. 5.4.3 Disease Research

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Atlanta Biologicals Inc.

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioLifeSolutions Inc.

      4. 6.1.4 Chart Industries Inc.

      5. 6.1.5 Hamilton Company

      6. 6.1.6 CENTOGENE N.V.

      7. 6.1.7 Sigma-Aldrich Inc. (Merck KGaA)

      8. 6.1.8 STEMCELL Technologies Inc.

      9. 6.1.9 Thermo Fisher Scientific Inc.

      10. 6.1.10 VWR International LLC

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Biobanks Market market is studied from 2018 - 2026.

The Biobanks Market is growing at a CAGR of 9.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • BioLifeSolutions Inc.
  • Hamilton Company
  • Sigma-Aldrich Inc. (Merck KGaA)
  • Thermo Fisher Scientific Inc.
  • VWR International LLC

Are the major companies operating in Biobanks Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!